US space manufacturing company Varda Space Industries has raised $251 million in Series D financing to expand its orbital ...

Swiss clinical-stage biotech Numab Therapeutics, which is advancing a proprietary pipeline of multi-specific antibodies in ...

Danish pharma major Novo today announced new data on how CagriSema (cagrilintide and semaglutide) works inside both the brain ...

French pharma major Sanofi and USA-based Regeneron Pharmaceuticals today announce an expansion of their longstanding antibody ...

The Centers for Medicare & Medicaid Services (CMS) has finalized the Global Benchmark for Efficient Drug Pricing (GLOBE) ...

South Korean biosimilar specialist Samsung Bioepis and Israel’s Teva Pharmaceutical Industries today announced that the ...

US pharma giant Pfizer presented detailed results from an ongoing Phase II study investigating tilrekimig (PF-07275315) in ...

NorthStar Medical Technologies, the US radiopharma company, has secured a multi-year growth capital facility of up to $185 ...

Following US Food and Drug Administration (FDA) approval in July, Celcuity says it has now launched Revtorpyk (gedatolisib) ...

US pharma giant Merck & Co has presented the first results from MK-7240-012, a Phase IIb trial of tulisokibart, an ...

Belgian biopharma UCB has presented new data at the European Academy of Dermatology and Venereology (EADV) 2026 Congress in ...

Swiss pure-play dermatology company Galderma will present new three-year data from the ARCADIA long-term extension study, ...